Jpmorgan Chase & CO Liva Nova PLC Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Liva Nova PLC stock. As of the latest transaction made, Jpmorgan Chase & CO holds 205,452 shares of LIVN stock, worth $10.1 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
205,452
Previous 474,561
56.71%
Holding current value
$10.1 Million
Previous $26.5 Million
57.58%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding LIVN
# of Institutions
256Shares Held
55.9MCall Options Held
566KPut Options Held
506K-
Black Rock Inc. New York, NY6.9MShares$338 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA5.98MShares$293 Million0.24% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.78MShares$136 Million0.07% of portfolio
-
State Street Corp Boston, MA2.05MShares$100 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.87MShares$91.5 Million0.0% of portfolio
About LivaNova PLC
- Ticker LIVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 53,545,700
- Market Cap $2.62B
- Description
- LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines,...